The global diabetes diagnostics market is projected to witness significant growth over the forecast period owing to the increasing incidence of diabetic patients across the globe. Additionally, the emergence of advanced technology coupled with the growing demand for round-the-clock self-monitoring is projected to boost the growth of the global diabetes diagnostic market.

Adroit Market Research report on the global diabetes diagnostics market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities, and challenges. The market has been studied for the period 2018 to 2028, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at the global as well as country level. In addition, the study also assesses the market competition with Porter's five forces analysis and company positioning based on their product portfolio, geographic footprint, strategic initiatives, and overall revenue. Prominent players operating in the global diabetes diagnostics market have been studied in detail.

North America currently holds the largest share in the diabetes diagnostics market owing to the presence of a significant number of major players across the region along with growing investments by the established firms. The regional growth is also attributed to the presence of a large patient pool and significant reimbursement scenario.

However, Asia Pacific is going to record growth at a faster pace on account of the growing geriatric population especially across emerging economies such as India, China, and Japan in particular. Furthermore, the market growth across the Asia Pacific region is attributed to the rising government focus on the development of advanced healthcare facilities for the growing population.

The prominent players operating in the global diabetes diagnostics market include BD, Johnson and Johnson, Roche Diagnostics Ltd, Bayer AG, Ypsomed AG, Abbott, Novo Nordisk A/S, Medtronic plc, Terumo Corporation, Acon Laboratories among other prominent players.

Key segments of the global diabetes diagnostics market

Product Type Overview, 2018-2028 (USD Million)

• Test Strips
• Lancets
• Analog Glucose Monitors
• Continuous Glucose Monitors
• Syringes
• Pens
• Pumps
• Injectors

End-Use Overview, 2018-2028 (USD Million)

• Hospitals/Clinics
• Homecare
• Diagnostic Centers

Regional Overview, 2018-2028 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• South America
  • Brazil
  • Mexico
  • Rest of South America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East and Africa